Published in N Engl J Med on November 10, 1994
Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. N Engl J Med (2013) 10.63
The molecular basis of T cell acute lymphoblastic leukemia. J Clin Invest (2012) 3.09
The role of the PTEN/AKT Pathway in NOTCH1-induced leukemia. Cell Cycle (2008) 1.83
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant (2010) 1.72
Phase 1/2 trial of total marrow and lymph node irradiation to augment reduced-intensity transplantation for advanced hematologic malignancies. Blood (2010) 1.62
Molecular pathogenesis and targeted therapies for NOTCH1-induced T-cell acute lymphoblastic leukemia. Blood Rev (2010) 1.54
Therapeutic targeting of NOTCH1 signaling in T-cell acute lymphoblastic leukemia. Clin Lymphoma Myeloma (2009) 1.13
Hematopoietic cell transplantation for children with acute lymphoblastic leukemia in second complete remission: similar outcomes in recipients of unrelated marrow and umbilical cord blood versus marrow from HLA matched sibling donors. Biol Blood Marrow Transplant (2009) 1.10
A proportional hazards regression model for the subdistribution with right-censored and left-truncated competing risks data. Stat Med (2011) 1.00
Transplant-related mortality following allogeneic hematopoeitic stem cell transplantation for pediatric acute lymphoblastic leukemia: 25-year retrospective review. Pediatr Blood Cancer (2013) 0.90
Hematopoietic stem cell transplantation for leukemia. Pediatr Clin North Am (2010) 0.90
A Mass Redistribution Algorithm for Right Censored and Left Truncated Time to Event Data. J Stat Plan Inference (2009) 0.77
Outcome of allogeneic hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia in second complete remission: a single institution study. Korean J Pediatr (2012) 0.77
Overexpression of SLC25A38 protein on acute lymphoblastic leukemia cells. Oncol Lett (2014) 0.76
Treatment of acute lymphoblastic leukemia in a second remission. N Engl J Med (1995) 0.75
Treatment of acute lymphoblastic leukemia in a second remission. N Engl J Med (1995) 0.75
In-vitro influence of mycophenolate mofetil (MMF) and Ciclosporin A (CsA) on cytokine induced killer (CIK) cell immunotherapy. J Transl Med (2016) 0.75
Outcome of Reinduction Chemotherapy with a Modified Dose of Idarubicin for Children with Marrow-Relapsed Acute Lymphoblastic Leukemia: Results of the Childhood Acute Lymphoblastic Leukemia (CALL)-0603 Study. J Korean Med Sci (2017) 0.75
Improved outcome in childhood ALL with intensive consolidation and hematopoietic stem cell transplant. Korean J Hematol (2010) 0.75
Immune rage against MAGE unleashed. Blood (2010) 0.75
CD19 Isoforms Enabling Resistance to CART-19 Immunotherapy Are Expressed in B-ALL Patients at Initial Diagnosis. J Immunother (2017) 0.75
Analysis of Dependently Truncated Data in Cox Framework. Commun Stat Simul Comput (2017) 0.75
Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med (1999) 5.82
Solid cancers after bone marrow transplantation. N Engl J Med (1997) 4.62
IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol (1997) 4.52
Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: unadjusted analysis. Bone Marrow Transplant (2001) 4.02
Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide. J Clin Oncol (1993) 3.41
Cell wall composition and virulence in Escherichia coli. J Exp Med (1968) 3.36
Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: Regression modeling. Bone Marrow Transplant (2001) 3.35
Plasma homocysteine levels and folate status in children with sickle cell anemia. J Pediatr Hematol Oncol (1999) 3.27
High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease. N Engl J Med (1994) 3.10
Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol (1997) 2.79
Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood (1999) 2.65
HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry. Ann Intern Med (1996) 2.52
Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review. J Thromb Haemost (2015) 2.46
Racial differences in the survival of childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study. J Clin Oncol (2000) 2.40
Association of Epstein-Barr virus with leiomyosarcomas in children with AIDS. N Engl J Med (1995) 2.38
Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet (1968) 2.29
Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood (1976) 2.29
T-cell depletion of HLA-identical transplants in leukemia. Blood (1991) 2.25
National cancer clinical trials: children have equal access; adolescents do not. J Adolesc Health (1997) 2.17
Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase. Blood (1993) 2.12
Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant (2001) 2.10
The acute chest syndrome of sickle cell disease. J Pediatr (1999) 2.04
Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood (1990) 1.98
New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. J Clin Oncol (2000) 1.92
Editors have ethical responsibilities, too. N Engl J Med (1984) 1.91
Testing for centre effects in multi-centre survival studies: a Monte Carlo comparison of fixed and random effects tests. Stat Med (1999) 1.88
A comparison study of parental adaptation following a child's death at home or in the hospital. Pediatrics (1983) 1.85
Serotype-specific immunoglobulin G antibody responses to pneumococcal polysaccharide vaccine in children with sickle cell anemia: effects of continued penicillin prophylaxis. J Pediatr (1996) 1.84
A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood (1979) 1.83
Should HLA-identical sibling bone marrow transplants for leukemia be restricted to large centers? Blood (1992) 1.77
Major hemorrhage in children with idiopathic thrombocytopenic purpura: immediate response to therapy and long-term outcome. J Pediatr (1998) 1.77
High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America. J Clin Oncol (1997) 1.75
Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion. Ann Intern Med (1988) 1.73
Availability and appropriateness of allogeneic bone marrow transplantation for chronic myeloid leukemia in 10 countries. N Engl J Med (1994) 1.71
Outcome after allogeneic bone marrow transplant for leukemia in older adults. JAMA (1993) 1.70
Factors in pathogenesis of central-nervous-system leukaemia. Br Med J (1972) 1.70
Home care for dying children: a nursing model. J Pediatr (1980) 1.69
Comparison of laparoscopic and open splenectomy in children with hematologic disorders. J Pediatr (1997) 1.67
A pilot study of outpatient management of febrile neutropenic children with cancer at low risk of bacteremia. J Pediatr (1996) 1.66
A retrospective analysis of the outcome of patients who have received two prior chemotherapy regimens including platinum and docetaxel for recurrent non-small-cell lung cancer. Lung Cancer (2003) 1.63
Value of C-reactive protein determination in the initial diagnostic evaluation of the febrile, neutropenic child with cancer. Pediatr Infect Dis J (1992) 1.61
Acute lymphoblastic leukemia with an unusual t(8;14)(q11.2;q32): a Pediatric Oncology Group Study. Leukemia (2000) 1.60
Bone-marrow transplantation for leukaemia. Lancet (1995) 1.60
Bone pain as an initial symptom of childhood acute lymphoblastic leukemia: association with nearly normal hematologic indexes. J Pediatr (1990) 1.59
Increasing incidence of adenovirus disease in bone marrow transplant recipients. J Infect Dis (1994) 1.57
Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease. Blood (1998) 1.57
Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study. Lancet (2002) 1.56
Childhood cancer in the United States. A geographical analysis of cases from the Pediatric Cooperative Clinical Trials groups. Cancer (1996) 1.56
Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant. Bone Marrow Transplant (2004) 1.55
Induction by alkylating agents of sister chromatid exchanges and chromatid breaks in Fanconi's anemia. Proc Natl Acad Sci U S A (1975) 1.55
Leptin increases uncoupling protein expression and energy expenditure. Am J Physiol (1997) 1.55
Severe combined immunodeficiency disease. Characterization of the disease and results of transplantation. JAMA (1977) 1.54
The changing epidemiology of bacteremia in neutropenic children with cancer. Pediatr Infect Dis J (1995) 1.52
Phase II investigational window using carboplatin, iproplatin, ifosfamide, and epirubicin in children with untreated disseminated neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol (1994) 1.51
Catheter-related thrombosis in children with cancer. J Pediatr (2001) 1.51
Seasonal variations in the diagnosis of childhood cancer in the United States. Br J Cancer (1999) 1.50
A prospective comparison of neuropsychologic performance of children surviving leukemia who received 18-Gy, 24-Gy, or no cranial irradiation. J Clin Oncol (1991) 1.50
Intensive oral methotrexate protects against lymphoid marrow relapse in childhood B-precursor acute lymphoblastic leukemia. J Clin Oncol (1996) 1.50
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer. JAMA (1999) 1.49
Residential pesticide exposure and neuroblastoma. Epidemiology (2001) 1.47
Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma. Bone Marrow Transplant (2008) 1.46
Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results. Blood (1989) 1.46
Selection of patients for bone marrow transplantation in severe aplastic anemia. Blood (1975) 1.46
Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases. Bone Marrow Transplant (2001) 1.46
Increased plasma endothelin-1 levels in fibromyalgia syndrome. Rheumatology (Oxford) (2003) 1.44
Malabsorption and defective utilization of iron in three siblings. J Pediatr (1981) 1.44
Bone marrow transplantation for Fanconi anemia. Blood (1995) 1.42
High-dose chemotherapy and autologous stem-cell transplantation for ovarian cancer: an autologous blood and marrow transplant registry report. Ann Intern Med (2000) 1.42
Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors. Ann Intern Med (1986) 1.42
Risk of adverse events in children completing treatment for acute lymphoblastic leukemia: St. Jude Total Therapy studies VIII, IX, and X. J Clin Oncol (1991) 1.42
Results of transplanting bone marrow from genetically identical twins into patients with aplastic anemia. Ann Intern Med (1997) 1.41
Outpatient management of febrile illness in infants and young children with sickle cell anemia. J Pediatr (1990) 1.41
Implantable venous access devices in children with hemophilia: a report of low infection rates. J Pediatr (1998) 1.40
How best to analyse new strategies in bone marrow transplantation. Bone Marrow Transplant (1990) 1.39
Treating acute lymphoblastic leukaemia after relapse: bone marrow transplantation or not? Lancet (1990) 1.39
Aplastic anemia (first of two parts): pathogenesis, diagnosis, treatment, and prognosis. N Engl J Med (1982) 1.38
High-dose melphalan with autologous marrow for treatment of advanced neuroblastoma. Br J Cancer (1982) 1.37
The t(1;14)(p34;q11) is nonrandom and restricted to T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood (1990) 1.36
Posthepatitic severe aplastic anemia--an indication for early bone marrow transplantation. Blood (1974) 1.36
Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia. J Clin Oncol (2000) 1.36